Merck KGaA
About Merck KGaA
Merck KGaA is a global science and technology company operating across life science, healthcare, and electronics. It translates scientific research into innovative tools, products, and partnerships that aim to advance health and technology worldwide. Headquartered in Darmstadt, Germany, the company serves customers globally and emphasizes digital innovation and sustainable practices. The branding emphasizes a vibrant, transformative approach to science and technology while maintaining a strong regional and international presence.
Recent News
Merck Partners Remepy in PDURS-Focused Alliance
Sanofi MS Drug Rejected in US Gets an Endorsement in Europe
Farther Finance Advisors LLC Raises Holdings in Merck & Co., Inc. $MRK
This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster
Pharma and Biotech Layoffs 2026 Watch
Merck KGaA Acquires JSR Chromatography Business
Parabilis Eyes $475m IPO to Push Lead Asset Into Phase III
Chip Industry Week In Review
Sanofi Posts Upbeat Sales as R&D Pressure Builds
StockWatch: Trump Order Lifts Psychedelic Drug Shares
What Does 17 Pharma MFN Deals Are Underneath the Press Releases: The Real Primary Source Stack, the GLP1 Numbers, TrumpRX Plumbing, and Where the New Adjudication Layer Gets Monetized
Merck’s PD-1/VEGF Data Star in Stacked Lineup of AACR ‘26 Data Reveals
New Data Build Case for Roche's Oral BTK Drug for MS
Gloo Holdings Inc (GLOO) Q1 2027 Earnings Call Transcript
Biocytogen and Sihuan Pharmaceutical Partner to Discover Novel Therapeutics in Multiple Indications
BMS Makes a Beeline, Bringing 5 Assets to Biotech's $300M Precision Immunology Debut
The Long and the Short of IT - the Week in Digibytes
Sanofi Defends Dupixent Patents, but Execs Insist It Has Nothing to Do with CEO Change
Module 4, Section 2: All About Assays
After Buying HUB and Partnering with Promega, MilliporeSigma Charts Growth Path in Organoids
EULAR 26 Hears of Treatment Advances in Lupus
Merck KGaA Lifts Full-Year Outlook as New CEO Kai Beckmann Drives Stronger Life‑science Performance
Syngene International Names Abhijit Zutshi as Chief Commercial Officer to Drive Global CRO Growth